A common cognitive disorder with symptoms that mimic Alzheimer's is often mistaken for the disease. Researchers are calling for criteria to diagnose the little-known condition.

Early research suggests GLP-1 drugs could prevent or treat Alzheimer's Disease. Results from a big clinical trial could soon confirm that.

Researchers in Scotland are developing a digital tool powered by artificial intelligence that can gauge your risk of ...

In a trial featuring a mouse model of Alzheimer's, scientists found that inhaling a mixture containing xenon gas helped ...

About a million Americans a year are expected to develop dementia by 2060, roughly double today’s toll, researchers reported ...

Regular aerobic exercise could significantly reduce disease markers associated with Alzheimer's, new research led by scientists at the University of Bristol (UK) and the Federal University of São ...

This manuscript describes the identification and characterization of 12 specific phosphomimetic mutations in the recombinant full-length human tau protein that trigger tau to form fibrils. This ...

Librarian Kathlynn Short armed with over 40 vibrant picture books, is on a mission to rekindle the joy of recognition in ...

There are two kinds of risk factors for dementia: non-modifiable and modifiable. Non-modifiable risk factors are ones that cannot be changed or eliminated, like aging, family history and genetics.

When Angi McClusky's husband Michael developed younger-onset Alzheimer's disease in 2015 just after his 65 th birthday, the ...

That underscores “the disproportionate burden of early-onset dementia, where patients face a lengthy course of the disease alongside the loss of productive and active years,” added Dumurgier ...

So when something's wrong with it, you might notice: White matter disease is different from Alzheimer's disease, which affects the brain's gray matter. If you're having memory problems or a loved ...